Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)

Completed

• Conditions: Glaucoma

• Registration Number: NCT03270761
• Lead Sponsor: Sun Yat-sen University

Brief Summary

This is a multi-center study to report the demographic profile, clinical features, and management in patients with Iridocorneal endothelial (ICE) syndrome in China.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-08-24
• Study First Submitted QC: 2017-08-30
• Study First Posted: 2017-09-01
• Study Start: 2017-09-10
• Primary Completion: 2019-12-12
• Study Completion: 2019-12-31
• Status Verified: 2021-06
• Last Update Submitted: 2021-06-06
• Last Update Posted: 2021-06-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

• Clinical diagnosis of ICE syndrome;
• Those willing to sign the informed consent.

Exclusion Criteria

• Patients who don't sign the informed consent or abide by the study procedure.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Management in patients with Iridocorneal endothelial (ICE) syndrome	through study completion, an average of 1 year	Record the number of medication treating corneal edema or glaucoma, and surgery (anti-glaucoma surgery, keratoplasty)

Secondary Outcome Measures

Name	Time	Method
Demographic profile of patients	1 day	Range of age, gender

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center; 🇨🇳 Guangzhou, Guangdong, China